The Board of Directors of the Company in their meeting held on 10.08.2026 i.e. today has inter-alia considered and approved the Unaudited Financial Results (both Standalone & Consolidated) ....

'i‘S icagen An I1SO 9001:2015 Company Date: 10t August, 2026 BSE Limited, Department of Corporate Services, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 BSE Scrip Code: 533014 Dear Sir/Madam, Sub: Outcome of Board meeting held on 10% August, 2026 This is to inform you that the Board of Directors of the Company at its meeting held today j.e. 10t August, 2026 has inter alia considered and approved the following: 1. Unaudited Financial Results for the Quarter ended 30" June, 2026 Unaudited Financial Results (both Standalone & Consolidated) of the Company for the Quarter ended 30% June, 2026. Pursuant to Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, copies of the aforesaid financial results | together with the limited review report of the Auditors are enclosed herewith. 2. Date of 22" Annual General Meeting (AGM), Book Closure and Record Date The 22" Annual General Meeting (AGM) of the Company will be held on Thursday, 17® September 2026 at 03:30 p.m. (IST) through video conferencing (VC) or other audio- visual means (OAVM). Book Closure Date The Register of Members and Share Transfer Books of the Company will be closed from Friday, 11t September 2026 till Thursday, 17% September 2026 (both days inclusive) for the purpose of 227 AGM. Record Date for Dividend The record date for the purpose of dividend, if any, declared at the 22n¢ AGM for the FY 2025-26 will be on closing hours of 10t September 2026 (Thursday) as per the list of beneficial owners furnished by National Securities Depository Ltd (NSDL) and Central Depository Services (India) Ltd. (CDSL). | Sicagen India Ltd. | Registered & Corporate Office: | 44 Floor, Spic House, 88, Mount Road, Guindy, Chennai 600032 INDIA Tel: +91 44 4075 4075 | Fax: +9144 40754099 | info@sicagen.com CIN.: L74900TN2004PLC053467 | www.sicagen.com 4S icagen An 1SO 9001:2015 Company The meeting of the Board of Directors commenced at 11:30 am. (IST) & concluded at 12:25 p.m. (IST). The above intimation be kindly be taken into record. Thanking You, Yours Sincerely, For Sicagen India Limited (Ankita Comp, Secretary Encl: As above Sicagen India Ltd. Registered & Corporate Office: 4% Floor, Spic House, 88, Mount Road, Guindy, Chennai 600 032 INDIA Tel: +91 44 4075 4075 | Fax: +9144 40754099 | info@sicagen.com CIN.: L74900TN2004PLC053467 | www.sicagen.com Standalone ‘S icagen Sicagen India Limited Regd Office : 4 Floor, SPIC House, No.88, Mount Road, Guindy, Chennai - 600032 CIN:L74900TN2004PLCO53467 Standalone Unaudited Financial Results for the quarter ended 30 June 2026 (Rs in lakhs except eamings per share data) Quarter ended Year ended Rarticulars 30.06.2026 | 31.03.2026 | 30.06.2025 31.03.2026 (Unaudited) (Audited) (Unaudited) (Audited) I. Income Revenue from Operations 13293 13969 12157 52027 Other Income 163 160 195 795 Total Revenue 13456 14129 12353 52822 Il. Expenses (@) Gost of materials consumed 1211 1040 854 3966 (b) Purchases of stock-in-trade 10747 11166 9904 42111 (c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (831) (10) (122) (263) (d) Employee benefits expense 471 463 448 1874 (e) Finance Cost 153 143 161 591 (f) Depreciation and amortisation expense 124 129 138 529 () Other expenses 634 828 481 2245 Total expenses 12708 13759 11844 51053 lll. Profit before exceptional items and tax (I - II) 747 370 509 1769 IV. Exceptional items (Net) = = = @1 V. Profit after exceptional items but before tax (Ill+IV) 747 370 509 1738 VI. Tax expense (1) Current tax 163 107 141 501 (2) Deferred tax 3% (52) 1 (54) Total Tax expense 199 55 142 447 VL. Net Profit / (Loss) for the period (V-VI) 548 315 367 1201 Vill. Other Comprehensive Income /Loss (a) Items that will not be reclassified to profit or loss: Remeasureofm deefninted employee benefit plans (15) (15) Equity Instruments through other comprehensive Income 1624 (2698) 883 (2737)] IX. Total Comprehensive Income (net oft ax) for the periodiyear (VI+VIll) 2172 (2396), 1250 (1461)| Attributable to: Shareholders of the Company 2172 (2398) 1250 (1481) X. Paid-up equity share capital 3057 3057 3057 3957 (Face Value of Rs.10/- each) XI. Other Equity Reserve excluding Revalution Reserves as 38134 per balance sheet of previous accounting year XIl. Earnings per share (Excluding OCl) Basic and Diluted EPS (of Rs. 10/- each) * 1.38 0.80 0.93 326 * Not been Annualised except for the year ended 31st March 2026 Standalone fiSicagen Sicagen India Limited Regd Office :4" Floor, SPIC House, No.88, Mount Road, Guindy, Chennai - 600032 CIN:L74900TN2004PLCO53467 Standalone Segmentwise Revenue, Results and Capital Employed for the quarter ended 30th June 2026 (Rs.in lakhs) Quarter ended Year ended S.No. Particulars 30.06.2026 | 31.03.2026 | 30.06.2025 | 31.03.2026 (Unaudited) | (Audited) | (Unaudited) | (Audited) A |SEGMENT REVENUE 2) Trading 12030 12692 10995 47139 b) Manufacturing 1263 1278 1163 4960 TOTAL 13293 13970 12158 52099 Less: Inter Segment Sales - 1 3 72 Net Income from Operations/Sales 13293 13969 12157 52027 B |SEGMENT RESULTS a) Trading 760 447 540 1820 b) Manufacturing 316 240 242 984 TOTAL 1076 687 782 2804 Less :Interest 137 133 146 553 Other Un-allocable Expenditure net of un-allocable Income 192 184 127 482 Total Profit before tax and Exceptional Items 747 370 509 1769 Exceptional items (Net) - - - (31) Total Profit before tax 747 370 509 1738 C |CAPITAL EMPLOYED (Segment Assets- Segment Lizbilities) SEGMENT ASSETS 2) Trading 17780 18556 18936 18556 b) Manufacturing 2723 2684 3088 2684 0) Other Un-allocable Assets 33867 30954 34043 30954 TOTAL 54350 52194 54067 52194 SEGMENT LIABILITIES a) Trading 8090 8430 7325 8430 b) Manufacturing 302 373 268 373 c) Other Un-allocable Liabilities 1695 1300 1276 1300 TOTAL 10087 10103 8869 10103 4S icagen STANDALONE Sicagen India Limited Regd Office :4™ Floor, SPIC House, No.88, Mount Road, Guindy, Chennai - 600032 CIN:L74900TN2004PLC053467 NOTES "Clause 2 of new uniform Listing Agreement read with Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 requires Companies to either publish standalone or consolidated financial results in the newspaper. The Company in compliance with this provision, has opted to publish the consolidated financial results. The standalone financial results will however be made available to BSE and will also be posted on the Company's website www.sicagen.com. The statement has been prepared in accordance with the Companies (Indian Accounting Standard) Rules, 2015 (Ind AS), prescribed under section 133 of the Companies Act 2013, and other recognized accounting practices and policies to the extent applicable. The above results of the Company were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 10.08.2026 and have been subjected to review by the Statutory Auditors of the Company. Segment Definition - Trading segment comprises of Building Materials, Power & Control Systems. Manufacturing segment relates to manufacture of Industrial Packaging, Specialty Chemicals. The figures for the last quarter ended March 31, 2026, are the balancing figures between the audited figures for the full financial year up to March 31, 2026, and the unaudited published year-to-date figures up to December 31, 2025, being the date of the end of third quarter of the financial year, which were subjected to limited review. Figures for the previous periods have been regrouped, reclassified and rearranged wherever necessary to confirm to the classification on the current year/ period’s classification. On behalf of the Board For Sicagen India Limited Place: Chennai Prasarina Joshi Date: 10.08.2026 Whole Time Director DIN -11702992 SRSV & ASSOCIATES Chartered Accountants INDIA Independent Auditor's Review Report on the Quarterly Unaudited Standalone Financial Results of the Company Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regu [Showing first 8,000 characters — download PDF for full document]